Suppr超能文献

口服髓鞘碱性蛋白对实验性自身免疫性脑脊髓炎的抑制作用。III. 脂多糖的协同效应。

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide.

作者信息

Khoury S J, Lider O, al-Sabbagh A, Weiner H L

机构信息

Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115.

出版信息

Cell Immunol. 1990 Dec;131(2):302-10. doi: 10.1016/0008-8749(90)90256-q.

Abstract

Oral administration of myelin basic protein (MBP) suppresses experimental autoimmune encephalomyelitis (EAE) in Lewis rats immunized with MBP in Freund's adjuvant. The immunomodulator bacterial lipopolysaccharide (LPS) when given orally in conjunction with MBP enhances the protective effects of MBP feeding in EAE. This synergy was achieved only following oral administration of LPS but not following subcutaneous injection. In contrast, subcutaneous administration of LPS abrogated oral tolerance. A synergism between oral LPS and MBP was also demonstrated for antigen-specific suppression of delayed type hypersensitivity (DTH) responses. Antibody responses to MBP were suppressed by oral administration of MBP but not by MBP plus LPS. The lipid A moeity of LPS mimicked the effects of LPS on disease protection and DTH suppression. These data demonstrate that adjuvants can enhance the induction of antigen-specific oral tolerance for suppression of cell-mediated experimental autoimmune responses.

摘要

口服髓鞘碱性蛋白(MBP)可抑制在弗氏佐剂中用MBP免疫的Lewis大鼠的实验性自身免疫性脑脊髓炎(EAE)。免疫调节剂细菌脂多糖(LPS)与MBP联合口服时,可增强MBP喂养对EAE的保护作用。这种协同作用仅在口服LPS后实现,皮下注射则未出现。相反,皮下注射LPS消除了口服耐受性。口服LPS和MBP之间的协同作用在抗原特异性抑制迟发型超敏反应(DTH)中也得到了证实。口服MBP可抑制对MBP的抗体反应,但MBP加LPS则无此作用。LPS的脂质A部分模拟了LPS对疾病保护和DTH抑制的作用。这些数据表明,佐剂可增强抗原特异性口服耐受性的诱导,以抑制细胞介导的实验性自身免疫反应。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验